424 related articles for article (PubMed ID: 32581102)
21. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
[TBL] [Abstract][Full Text] [Related]
23. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB
J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863
[TBL] [Abstract][Full Text] [Related]
25. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
Araujo I; Foss HD; Bittencourt A; Hummel M; Demel G; Mendonca N; Herbst H; Stein H
Blood; 1996 Jun; 87(12):5279-86. PubMed ID: 8652843
[TBL] [Abstract][Full Text] [Related]
26. Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.
Muriuki BM; Forconi CS; Oluoch PO; Bailey JA; Ghansah A; Moormann AM; Ong'echa JM
Sci Rep; 2021 May; 11(1):11343. PubMed ID: 34059753
[TBL] [Abstract][Full Text] [Related]
27. Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.
Correia S; Palser A; Elgueta Karstegl C; Middeldorp JM; Ramayanti O; Cohen JI; Hildesheim A; Fellner MD; Wiels J; White RE; Kellam P; Farrell PJ
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515295
[TBL] [Abstract][Full Text] [Related]
28. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
30. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.
Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients.
Salahuddin S; Khan J; Azhar J; B. Whitehurst C; Qadri I; Shackelford J; Pagano JS; Muhammad D; Richards KL
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3153-3159. PubMed ID: 30486603
[TBL] [Abstract][Full Text] [Related]
32. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
33. Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells.
Lin Z; Xu G; Deng N; Taylor C; Zhu D; Flemington EK
J Virol; 2010 Dec; 84(24):13053-8. PubMed ID: 20943983
[TBL] [Abstract][Full Text] [Related]
34. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
Chang CM; Yu KJ; Mbulaiteye SM; Hildesheim A; Bhatia K
Virus Res; 2009 Aug; 143(2):209-21. PubMed ID: 19596032
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
36. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.
Aguirre AJ; Robertson ES
Virology; 1999 Nov; 264(2):359-69. PubMed ID: 10562498
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
[TBL] [Abstract][Full Text] [Related]
38. Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma.
Oluoch PO; Oduor CI; Forconi CS; Ong'echa JM; Münz C; Dittmer DP; Bailey JA; Moormann AM
J Infect Dis; 2020 Jun; 222(1):111-120. PubMed ID: 32072172
[TBL] [Abstract][Full Text] [Related]
39. The genetic diversity of Epstein-Barr virus in the setting of transplantation relative to non-transplant settings: A feasibility study.
Allen UD; Hu P; Pereira SL; Robinson JL; Paton TA; Beyene J; Khodai-Booran N; Dipchand A; Hébert D; Ng V; Nalpathamkalam T; Read S
Pediatr Transplant; 2016 Feb; 20(1):124-9. PubMed ID: 26578436
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
